Related Products

Summary Of Paxalisib-API-Small Molecules

Chemical Name

Paxalisib

CAS No.

1382979-44-3

Molecular Formula

C18H22N8O2

Innovator

Developer

Indication

Glioblastoma; Recurrent Glioblastoma

Therapeutic Area

Oncology

Market Status

Phase 3

Approval Year

Patent Expiry